Evidence map›Paper›PMID 39867997›Full record

ReviewOne health (Amsterdam, Netherlands)2025

Microbial biopesticides: A one health perspective on benefits and risks.

Panqin Cai, George Dimopoulos

Abstract readReview
In one paragraph

Review in One health (Amsterdam, Netherlands), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Rethinking microbial biopesticide development and uptake.World journal of microbiology & biotechnology · 2026
    Review
  3. Article
  4. Review
  5. Journal of bacteriology · 2026
    Review
  6. ExploringMicrobiology (Reading, England) · 2026
    Review
  7. Microbial Biotechnology in Agriculture.Progress in molecular and subcellular biology · 2026
    Review
  8. Article
  9. Review
  10. Use ofBiology · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Panqin CaiDepartment of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University, Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA.
George DimopoulosDepartment of Molecular Microbiology and Immunology, Johns Hopkins Malaria Research Institute, Johns Hopkins University, Bloomberg School of Public Health, 615 N Wolfe St, Baltimore, MD 21205, USA.

Funding

Mosquito SAMSP1 and SAMSP2 influence the initial stage of Plasmodium infection of miceR01AI158615 · NIAID · YALE UNIVERSITY · PI DIMOPOULOS, GEORGE, FIKRIG, EROL · 2021 to 2025
$4.1M
Impact of gene-drive systems for population modification on malaria vector mosquitoesR01AI170692 · NIAID · UNIVERSITY OF CALIFORNIA-IRVINE · PI DIMOPOULOS, GEORGE, JAMES, ANTHONY A. · 2023 to 2025
$3.2M
NIAID NIH HHS R01 AI158615NIAID NIH HHS R01 AI170692
6 · The paper itself

Abstract

Controlling insect pests that destroy crop and spread diseases will become increasingly crucial for addressing the food demands of a growing global population and the expansion of vector-borne diseases. A key challenge is the development of a balanced approach for sustainable food production and disease control in 2050 and beyond. Microbial biopesticides, derived from bacteria, viruses, fungi, protozoa, or nematodes, offer potentially significant benefits for promoting One Health and contributing to several United Nations Sustainable Development Goals (SDGs). This narrative review examines the benefits and risks of microbial biopesticides from a One Health perspective, focusing on the Americas and Europe, and aligned with respective SDGs. The value of biopesticides in sustainable agriculture and integrated pest management (IPM) approaches for food security, particularly SDG 2 (Zero Hunger) and SDG 1 (No Poverty) has been widely recognized, with relatively fewer adverse effects to people and the environment than synthetic pesticides. With increased demand and usage, microbial biopesticides can be expected to contribute further to additional SDGs such as SDG 12 (responsible consumption and production) through waste recycling for biopesticide production and remediation of polluted ecosystems, and by reducing vector-borne disease burdens such as malaria and dengue. Nevertheless, the prudent and judicious application of microbial biopesticides is crucial to ensuring their effectiveness and maximizing their One Health benefits while minimizing pest resistance and unintended impacts. From a One Health perspective, this goal involves incorporating microbial biopesticides into a comprehensive biological control strategy within an IPM framework for sustainable agriculture and for controlling vector-borne diseases.

Indexed as

Animal healthBiological control agentsBiopesticidesCrop pestsEnvironmental healthFood securityIntegrated pest managementIntegrated vector managementMosquito controlOrganic farmingPlant healthPublic healthSustainable agricultureVectored human diseases

Identifiers

PMID39867997
PMCPMC11762943

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.